Sickle Cell Program

Yale-New Haven Hospital offers a comprehensive program to meet the needs of patients with sickle cell anemia, also known as sickle cell disease. The Sickle Cell Program's objectives are to educate patients, families,health care providers and the wider community about sickle cell disease, and reduce the number of hospitalizations and emergency room visits.

Our program offers high-risk adults the opportunity to be seen in the YNHH Hematology Clinic.

Children receive care in the pediatric sickle cell program at Yale-New Haven Children's Hospital.

Patients and providers can consult with Smilow Cancer Hospital hematologist 24/7 by calling 203-200-4363

About Sickle Cell Disease

Sickle Cell Anemia (SCA) is an inherited disease of the red blood cells. It is characterized by painful episodes, lower resistance to infections, organ damage, anemia, joint degeneration, strokes and other health problems. SCA occurs when a child inherits a hemoglobin gene that sickles from both parents and is born with the disease.

Sickle Cell Trait (SCT) occurs when a child inherits a normal hemoglobin gene and a sickle gene. This individual is a carrier of the sickle cell gene. SCT is harmless for the carrier, however, the abnormal gene can be passed on if both mother and father are carriers of the gene.

Sickle cell disease is most prevalent in African-American and Latino populations. The disease/trait is found among people whose ancestors came from Africa, Greece, Italy, Arabia, India, Asia and the Caribbean.

Find more information about sickle cell disease:

Online Health Library

Sickle Cell Disease Association of America - Southern Connecticut